UTILISATION D'INHIBITEURS DE PHOSPHATASE OU D'INHIBITEURS D'HISTONE DÉSACÉTYLASE POUR TRAITER DES MALADIES CARACTÉRISÉES PAR LA PERTE D'UNE FONCTION PROTÉIQUE
LIXTE BIOTECHNOLOGY;THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; INC.;LIXTE BIOTECHNOLOGY, INC.
发明人:
KOVACH, JOHN, S.,ZHUANG, ZHENGPING,LU, JIE,YANG, CHUNZHANG,LONSER, RUSSELL
申请号：
EP12790255
公开号：
EP2714924A4
申请日:
2012.05.24
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
A method of treating a mammalian subject afflicted with a disease characterized by a loss of protein function caused by a genetic abnormality associated with the disease comprising administering to the subject a therapeutically effective amount of a protein phosphatase 2A inhibitor or a histone deacetylase inhibitor.
